BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10023954)

  • 21. Effects of various anorexigenic agents on open field behavior of rats.
    Maickel RP; Johnson SA
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):733-9. PubMed ID: 4750110
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative effects of four antiobesity agents on blood plasma lipids in man.
    Mace PM; Malcolm AD; Outar KP; Pawan GL
    Proc Nutr Soc; 1972 May; 31(1):14A-15A. PubMed ID: 5048465
    [No Abstract]   [Full Text] [Related]  

  • 23. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
    Callahan BT; Yuan J; Ricaurte GA
    Synapse; 2000 Dec; 38(4):471-6. PubMed ID: 11044894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental evaluation of anorexigenic agents in man: a pilot study.
    Malcolm AD; Mace PM; Outar KP; Pawan GL
    Proc Nutr Soc; 1972 May; 31(1):12A-14A. PubMed ID: 5048464
    [No Abstract]   [Full Text] [Related]  

  • 25. The central hypotensive action of amphetamine, ephedrine, phentermine, chlorphentermine and fenfluramine.
    Hoyer I; Van Zwieten PA
    J Pharm Pharmacol; 1972 Jun; 24(6):452-8. PubMed ID: 4403827
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior of blood pressure during chronic effect of phenylalkylamines].
    Kemper F
    Arzneimittelforschung; 1969 Oct; 19(10):1702-4. PubMed ID: 5395371
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anorexics. 25].
    Sachweh H
    Pharm Prax; 1968; 6():138-40. PubMed ID: 4886594
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of administration of dexfenfluramine and phentermine, alone and in combination, on ingestive behavior and body weight in rats.
    Roth JD; Rowland NE
    Psychopharmacology (Berl); 1998 May; 137(1):99-106. PubMed ID: 9631962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the effect of anorectic drugs on striatum homovanillic acid in rats.
    Jori A; Dolfini E
    Pharmacol Res Commun; 1974 Apr; 6(2):175-8. PubMed ID: 4438398
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influence of anorectics of the amphetamine series on the behavior of the Siamese warrior fish Betta splendens].
    Weischer ML
    Arzneimittelforschung; 1966 Oct; 16(10):1310-1. PubMed ID: 6014914
    [No Abstract]   [Full Text] [Related]  

  • 31. Valvular heart disease associated with fenfluramine-phentermine.
    Redmon B; Raatz S; Bantle JP
    N Engl J Med; 1997 Dec; 337(24):1773-4; author reply 1775. PubMed ID: 9411249
    [No Abstract]   [Full Text] [Related]  

  • 32. Is phentermine an inhibitor of monoamine oxidase? A critical appraisal.
    Rothman RB
    Synapse; 1999 May; 32(2):141-5. PubMed ID: 10231134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields.
    Lew R; Weisenberg B; Vosmer G; Seiden LS
    Synapse; 1997 May; 26(1):36-45. PubMed ID: 9097403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modification of the cerebral serotonin level in the rat by trifluoromethyl-2-phenyl ethyl aminopropane (Fenfluramine 768 S)].
    Duhault J; Verdavainne C
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):276-86. PubMed ID: 5299781
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of anorexigenic and behavioral potency of phenylethylamines.
    Cox RH; Maickel RP
    J Pharmacol Exp Ther; 1972 Apr; 181(1):1-9. PubMed ID: 5066966
    [No Abstract]   [Full Text] [Related]  

  • 36. The contribution of increased thermogenesis to the effect of anorectic drugs on body composition in mice.
    Arch JR
    Am J Clin Nutr; 1981 Dec; 34(12):2763-9. PubMed ID: 7315777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of phentermine.
    Yelnosky J; Panasevich RE; Borrelli AR; Lawlor RB
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):62-76. PubMed ID: 5353475
    [No Abstract]   [Full Text] [Related]  

  • 38. Phentermine+fenfluramine produce cocaine-like discriminative cues.
    Schechter MD; McBurney D
    Life Sci; 1996; 59(20):PL303-8. PubMed ID: 8890951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical use of appetite suppressants.
    Silverstone T
    Drug Alcohol Depend; 1986 Jun; 17(2-3):151-67. PubMed ID: 3527636
    [No Abstract]   [Full Text] [Related]  

  • 40. Dental considerations of patients taking appetite suppressants.
    Wynn RL
    Gen Dent; 1997; 45(4):324-8, 330-1. PubMed ID: 9515435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.